DalsnaFinance › IPOs › Nuvectis Pharma Inc › IPO
Nuvectis Pharma, Inc. completed its initial public offering on NASDAQ on February 4, 2022, pricing at $5.00 a share.
| Ticker | NVCT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | February 4, 2022 |
| Offering price | $5.00 |
| Shares offered | 3,200,000 |
| Total raised | $16M |
Nuvectis Pharma, Inc. sold 3,200,000 shares at $5.00 each on NASDAQ. Multiplied out, that is $16 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $16 million total recorded for the deal.
Nuvectis Pharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Nuvectis Pharma, Inc.. This page is general information, not investment advice.